Córdoba VF

Language: Spanish
References: 10
Page: 673-675
PDF size: 139.63 Kb.

ABSTRACT

This article was written with the intention of reviewing the risk factors of thromboembolic disease, patients’ classification according to risk and preventive therapeutic measures.

REFERENCES

1. Frederick A. Anderson Jr. “Risk Factors for Venous Thromboembolism.” Circulation. American Heart Association, n.d. Web.

2. Greenfield, Lazar J., and Michael W. Mulholland. Greenfield’s Surgery: Scientific Principles and Practice. Philadelphia, PA: Lippincott Williams & Wilkins, 2006. Print

3. “Heparin (Rx)Brand and Other Names:.” Heparin Dosing, Indications, Interactions, Adverse Effects, and More. Medscape, n.d. Web. 22 Jan. 2016

4. Jonathan Laryea. “Venous Thromboembolism Prophylaxis.” PubMed. Clinics in Colon and Rectal Surgery, Sept. 2013. Web.

5. Jorge A. Pérez Castro Y Vázquez, “Lista De Cotejo De Caprini Modificada Como Una Estrategia Para La Aplicación De Un Programa De Seguridad Del Paciente En La Prevención De La Enfermedad Tromboembólica.” Medigraphic 33.3 (2011): 151-55. Asociación Mexicana De Cirugía General, 15 Sept. 2011. Web. .

6. Menaka Pai, MD, FRCPC, and James D Douketis, MD, FRCPC, FACP, FCCP. “Prevention of Venous Thromboembolic Disease in Surgical Patients.” Up to Date. N.p., 01 Dec. 2015. Web.

7. Segura, Donato A. Salas. “Tromboembolismo Venoso Diagnóstico Y Manejo. Primera Parte.” Revista Médica Universidad Costa Rica Sept. 2009: 7-15. Web.

8. Segura, Donato A. Salas. “Tromboembolismo Venoso. Diagnóstico Y Manejo. Parte II.” Revista Médica De La Universidad De Costa Rica 4.1 (2010).

9. Schwartz, Seymour I., and F. Charles. Brunicardi. Schwartz’s Manual of Surgery. New York: McGraw-Hill Medical Pub. Division, 2006. Print.

10. “Warfarin (Rx)Brand and Other Names:Coumadin, Jantoven.” Coumadin, Jantoven (warfarin) Dosing, Indications, Interactions, Adverse Effects, and More. Medscape, n.d. Web. 22 Jan. 2016.